The Federal Joint Committee (G-BA) commissioned the German Institute for Quality and Efficiency in Health Care (IQWiG) to investigate whether Trifarotene offers benefit for patients aged twelve years and older.
from Medindia Health News https://ift.tt/38SPshc
No comments:
Post a Comment